重要日期
  • 注册日期
    2016年3月1日
  • 摘要提交日期
    2016年3月1日
  • 摘要提交截止日期
    2016年8月31日
  • 摘要退出
    2016年9月9日
  • 墙报接收通知
    2016年9月10日
  • 短报告通知
    2016年9月25日
新闻
欢迎辞

8th International Conference

SUMO, Ubiquitin, UBL Proteins: 
Implications for Human Diseases

Oct. 21-23, 2016 | Shanghai, China 

March 18, 2016

 

Dear Friends,

The Eighth International Conference is dedicated to the 20th year celebration of the discovery of SUMO.   In 1996, several laboratories reported a novel ubiquitin-like protein that was named Sentrin, GMP-1, PIC-1, and UBL1.  This ubiquitin-like protein was shown to interact or modify FAS, RanGAP1, and PML.  The SUMO conjugating and de-conjugating enzymes were quickly discovered and they dwarfed in size to the ubiquitin enzymes.  Thus, the early workers in this field thought SUMO only modifies a limited number of substrates.   However, we continue to be surprised by the versatility of the SUMO pathway.  Thousands of SUMO substrates have now been reported and the biology of SUMO spans the entire spectrum of cell function and disease processes.  The first decade of SUMO world depicted a parallel universe with the ubiquitin system; however, the second decade witnessed a collision of the SUMO and ubiquitin galaxies to create a new concept of SUMO-dependent ubiquitin-mediated protein degradation.  The early biochemistry has entered cell biology and now explored at an organism level.  Numerous disease processes and drug targets have been discovered in the field of ubiquitin and ubiquitin-like proteins.  It is indeed a very exciting time!  The Eight International Conference will continue our tradition of collegiality, discovery, and excellence.   We will bring together world’s best scientists to gather in Shanghai to renew old friendships and to establish new ones.

 

Happy birthday SUMO!

 

Guo-Qiang Chen and Edward T.H. Yeh

 

Copyright © 2016 第八届"SUMO, 泛素, UBL蛋白与人类疾病"国际会议 版权所有.

访问量:技术支持:维程互联